查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612174

兽用抗生素和抗菌药物市场：副产品、给药方式、形式和动物类型 - 2025-2030年全球预测

Animal Antibiotics & Antimicrobials Market by Product (Antibiotics, Antimicrobial), Mode of Delivery (Injections, Oral), Form, Type of Animal - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年兽用抗生素及抗菌药物市值为6.3551亿美元，预计2024年将达到6.6723亿美元，复合年增长率为5.25%，2030年将达9亿美元，预计将达到984万美元。

兽用抗生素和抗菌药物市场的定义是专门针对动物微生物感染的预防和治疗的产品，从而确保动物健康并提高牲畜的粮食生产生产力。由于动物族群中疾病传播的风险不断增加、提高生长速度和饲料效率的需求以及全球对动物性食品的需求不断增加，因此需要这个市场。应用范围涵盖兽医、牲畜管理、宠物护理和水产养殖，最终用户包括农民、兽医和製药商。人们对动物健康问题的认识不断提高、兽医学的进步以及全球肉类消费的扩大推动了市场的成长。然而，新兴国家也存在着巨大的商机，特别是在亚太地区和南美洲，这些国家的畜牧业随着都市化而不断扩张。影响成长的关键因素包括抗菌药物和替代产品的创新、鼓励减少抗生素使用的法律规范以及增加对兽医保健的投资。相反，市场成长面临严格监管、对抗生素抗药性日益担忧以及对无抗生素和有机农业日益支持等挑战。透过分子诊断和精准医学进行的个人化治疗创新，以及益生菌和草药抗菌剂等替代产品的开发，为业务扩张提供了潜力。市场性质的趋势揭示了综合健康管理解决方案的趋势，该解决方案涉及整个食品供应链的协作，以确保永续性和合规性。回应监管变化，投资新的永续产品的研发，并加强与动物用药品整体相关人员的策略伙伴关係，以优化成长潜力，同时克服市场挑战。总体而言，展望强调推进动物用药品健康解决方案和减轻与抗菌素抗药性相关的公共卫生问题之间的平衡。

主要市场统计
基准年[2023] 63551万美元
预计年份 [2024] 66723万美元
预测年份 [2030] 9.0984亿美元
复合年增长率（%） 5.25%

市场动态：快速发展的兽用抗生素和抗菌素市场的关键市场洞察

供需的动态交互作用正在改变兽用抗生素和抗菌药物市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 畜产量需求增加，青霉素类抗生素需求旺盛
    • 政府加强对牲畜传染病控制的参与
    • 动物疾病治疗开发的资本投入大幅增加
  • 市场限制因素
    • 对抗生素抗药性的担忧、严格的监管核准
  • 市场机会
    • 最先进的研发设施并加速开发新药活动
    • 人们越来越关注新型抗菌药物的永续性
  • 市场问题
    • 替代品的可用性

波特五力：驾驭兽用抗生素和抗菌药物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对兽用抗生素和抗菌药物市场的影响

外部宏观环境因素对兽用抗生素和抗菌药物市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解兽用抗生素及抗菌药物市场竞争状况

兽用抗生素和抗菌药物市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：兽用抗生素和抗菌药物市场供应商的绩效评估

FPNV定位矩阵是评估兽用抗生素和抗菌药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划兽用抗生素和抗生素市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对兽用抗生素和抗菌药物市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 畜产品和青霉素抗生素的需求增加
      • 加强政府参与对抗动物疾病爆发
      • 动物疾病治疗方法研发的资本投入大幅增加
    • 抑制因素
      • 对抗生素抗药性的担忧 严格的监管核准
    • 机会
      • 加速先进的研发设施和开发新药活动
      • 更加关注新型抗菌药物的永续性
    • 任务
      • 替代品的可用性
  • 市场区隔分析
    • 产品：疾病预防和治疗对抗生素的需求不断增长
    • 给药方法：由于它是一种非侵入性操作，因此口服给药的趋势不断增加。
    • 形式：增加使用抗菌溶液来治疗严重细菌感染疾病的个别动物
    • 动物类型：宠物对抗生素和抗菌药物的需求不断增长，以控制细菌感染
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章兽用抗生素/抗生素市场：副产品

  • 介绍
  • 抗生素
  • 抗菌的

第七章 兽用抗生素/抗生素市场：依管理方式分类

  • 介绍
  • 注射
  • 口服

第八章兽用抗生素/抗生素市场：依形式

  • 介绍
  • 粉末和锭剂
  • 解决方案

第九章兽用抗生素/抗生素市场：依动物类型

  • 介绍
  • 伴同性动物
    • 猫
    • 狗
    • 马
  • 食用动物
    • 牛
    • 猪
    • 家禽
    • 绵羊和山羊

第10章：美洲兽用抗生素和抗菌药物市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太兽用抗生素和抗菌药物市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲兽用抗生素及抗菌药物市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Zoetis 在美国商业推出 Librera（维丁贝托单抗注射液），展现了狗狗的创新
    • Huvepharma 将唯一经 FDA核准的三重磺胺药物返回美国市场
    • Elanco 和 Ginkgo Bioworks 推出 BiomEdit，这是一家利用微生物组技术的新动物保健公司
  • 战略分析和建议

公司名单

  • American Regent Inc.
  • Ayurvet
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Eli Lilly and Company
  • Endovac Animal Health, LLC
  • Hester Biosciences Limited
  • Hipra Laboratories, SA
  • Inovet Group
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Novartis AG
  • Phibro Animal Health Corporation
  • Sanofi-Aventis Groupe SA
  • Tianjin Ringpu BIoTechnology Co., Ltd.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis, Inc.
  • Zydus Pharmaceuticals, Inc.
Product Code: MRR-031BF22F949D

The Animal Antibiotics & Antimicrobials Market was valued at USD 635.51 million in 2023, expected to reach USD 667.23 million in 2024, and is projected to grow at a CAGR of 5.25%, to USD 909.84 million by 2030.

The Animal Antibiotics & Antimicrobials market is defined by products explicitly aimed at preventing and treating microbial infections in animals, thus securing animal health and improving productivity in livestock for food production. This market is necessitated by the heightened risk of disease spread in animal populations, the need to enhance growth rates and feed efficiency, and an increasing global demand for animal-derived food products. Its application spans across veterinary medicine, livestock management, pet care, and aquaculture, with end-users ranging from farmers and veterinarians to pharmaceutical manufacturers. Market growth is driven by rising awareness of animal health issues, advancements in veterinary medicine, and growing global meat consumption. However, significant opportunities lie in emerging economies where livestock industries are concurrently expanding with urbanization, particularly in Asia-Pacific and South America. Key influencing growth factors include technological innovation in antimicrobial and alternative products, regulatory frameworks encouraging reduced antibiotic use, and increased investment in veterinary healthcare. Conversely, market growth faces challenges such as stringent regulations, rising antibiotic resistance concerns, and growing advocacy for antibiotic-free and organic farming. Innovations in molecular diagnostics and precision medicine for tailored treatment, coupled with the development of alternative products such as probiotics and herbal antimicrobials, present potential areas for business expansion. Insights into the market nature reveal a trend towards integrated health management solutions involving collaboration across the food supply chain to ensure sustainability and compliance. Adapting to regulatory changes, investing in R&D for novel and sustainable products, and enhancing strategic partnerships with stakeholders across the animal health spectrum are recommended strategies to navigate market challenges while optimizing growth potential. Overall, the future outlook underscores a balance between advancing animal health solutions and mitigating public health concerns related to antimicrobial resistance.

KEY MARKET STATISTICS
Base Year [2023] USD 635.51 million
Estimated Year [2024] USD 667.23 million
Forecast Year [2030] USD 909.84 million
CAGR (%) 5.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Antibiotics & Antimicrobials Market

The Animal Antibiotics & Antimicrobials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for livestock products and strong demand for penicillin based antibiotics
    • Increasing government involvement in countering animal diseases outbreaks
    • Growing huge capital investment for the development of drugs for animal diseases
  • Market Restraints
    • Concerns regarding resistance to antibiotic stringent regulatory approvals
  • Market Opportunities
    • Accelerating advanced research and development facilities, and new drug development activities
    • Growing focus towards sustainability of new antimicrobials
  • Market Challenges
    • Availability of substitutes

Porter's Five Forces: A Strategic Tool for Navigating the Animal Antibiotics & Antimicrobials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Antibiotics & Antimicrobials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Antibiotics & Antimicrobials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Antibiotics & Antimicrobials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Antibiotics & Antimicrobials Market

A detailed market share analysis in the Animal Antibiotics & Antimicrobials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Antibiotics & Antimicrobials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Antibiotics & Antimicrobials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Antibiotics & Antimicrobials Market

A strategic analysis of the Animal Antibiotics & Antimicrobials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibiotics & Antimicrobials Market, highlighting leading vendors and their innovative profiles. These include American Regent Inc., Ayurvet, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Inovet Group, Neogen Corporation, Norbrook Laboratories Ltd., Novartis AG, Phibro Animal Health Corporation, Sanofi-Aventis Groupe S.A., Tianjin Ringpu Biotechnology Co., Ltd., Vetoquinol S.A., Virbac S.A., Zoetis, Inc., and Zydus Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibiotics & Antimicrobials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antibiotics and Antimicrobial.
  • Based on Mode of Delivery, market is studied across Injections and Oral.
  • Based on Form, market is studied across Powders & Tablets and Solutions.
  • Based on Type of Animal, market is studied across Companion Animals and Food-Producing Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Food-Producing Animals is further studied across Cattle, Pigs, Poultry, and Sheep & Goats.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for livestock products and strong demand for penicillin based antibiotics
      • 5.1.1.2. Increasing government involvement in countering animal diseases outbreaks
      • 5.1.1.3. Growing huge capital investment for the development of drugs for animal diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns regarding resistance to antibiotic stringent regulatory approvals
    • 5.1.3. Opportunities
      • 5.1.3.1. Accelerating advanced research and development facilities, and new drug development activities
      • 5.1.3.2. Growing focus towards sustainability of new antimicrobials
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of substitutes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing need for antibiotics for disease prevention and treatment
    • 5.2.2. Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure
    • 5.2.3. Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections
    • 5.2.4. Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Antibiotics & Antimicrobials Market, by Product

  • 6.1. Introduction
  • 6.2. Antibiotics
  • 6.3. Antimicrobial

7. Animal Antibiotics & Antimicrobials Market, by Mode of Delivery

  • 7.1. Introduction
  • 7.2. Injections
  • 7.3. Oral

8. Animal Antibiotics & Antimicrobials Market, by Form

  • 8.1. Introduction
  • 8.2. Powders & Tablets
  • 8.3. Solutions

9. Animal Antibiotics & Antimicrobials Market, by Type of Animal

  • 9.1. Introduction
  • 9.2. Companion Animals
    • 9.2.1. Cats
    • 9.2.2. Dogs
    • 9.2.3. Horses
  • 9.3. Food-Producing Animals
    • 9.3.1. Cattle
    • 9.3.2. Pigs
    • 9.3.3. Poultry
    • 9.3.4. Sheep & Goats

10. Americas Animal Antibiotics & Antimicrobials Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Animal Antibiotics & Antimicrobials Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Animal Antibiotics & Antimicrobials Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Zoetis Demonstrates Canine Innovation with Commercial Launch of Librela (bedinvetmab injection) in the U.S.
    • 13.3.2. Huvepharma Returns The Only FDA-Approved Triple-Sulfa Medication To US Market
    • 13.3.3. Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. American Regent Inc.
  • 2. Ayurvet
  • 3. Bayer AG
  • 4. Boehringer Ingelheim GmbH
  • 5. Ceva Sante Animale
  • 6. Chanelle Pharma
  • 7. Dechra Pharmaceuticals PLC
  • 8. Eco Animal Health Group PLC
  • 9. Elanco Animal Health Incorporated
  • 10. Eli Lilly and Company
  • 11. Endovac Animal Health, LLC
  • 12. Hester Biosciences Limited
  • 13. Hipra Laboratories, S.A.
  • 14. Inovet Group
  • 15. Neogen Corporation
  • 16. Norbrook Laboratories Ltd.
  • 17. Novartis AG
  • 18. Phibro Animal Health Corporation
  • 19. Sanofi-Aventis Groupe S.A.
  • 20. Tianjin Ringpu Biotechnology Co., Ltd.
  • 21. Vetoquinol S.A.
  • 22. Virbac S.A.
  • 23. Zoetis, Inc.
  • 24. Zydus Pharmaceuticals, Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POWDERS & TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 278. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 279. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023